| 【英文篇名】 |
Cost-Effectiveness Analysis of Cefoperazone Sodium/Sulbactam Sodium vs. Levofloxacin in the Treatment of Community Acquired Pneumonia |
| 【作者】 |
张玉娥; 韦超霞; |
| 【英文作者】 |
ZHANG Yu-e（Dept. of Clinical Pharmacy; Guangdong Jiangmen Municipal Wuyi Hospital of TCM&The Sixth Affiliated Hospital of Medical College of Ji'nan University; Jiangmen 529000; China）WEI Chao-xia（Guilin Medical College; Guilin 541004; China）; |
| 【作者单位】 |
广东江门市五邑中医院/暨南大学医学院第六附属医院临床药学室; 桂林医学院; |
| 【刊名】 |
中国药房 , China Pharmacy, 编辑部邮箱 2008年 08期
期刊荣誉：中文核心期刊要目总览 ASPT来源刊 中国期刊方阵 CJFD收录刊 |
| 【关键词】 |
社区获得性肺炎; 头孢哌酮/舒巴坦钠; 左氧氟沙星; 成本-效果分析; |
| 【英文关键词】 |
Community acquired pneumonia; Cefoperazone sodium/sulbactam sodium; Levofloxacin; Cost-effectiveness analysis; |
| 【摘要】 |
目的:探讨2种药物治疗方案对社区获得性肺炎的经济效果。方法:采用回顾性研究方法,选择88例社区获得性肺炎患者,分别给予头孢哌酮钠/舒巴坦钠组(A组)、左氧氟沙星组(B组),观察2组疗效并进行成本-效果分析。结果:A组与B组成本分别为1803·91、1599·81元(P>0·05),有效率分别为95·0%、100·0%(P>0·05),成本-效果比分别为1898·85、1599·81。结论:B组方案优于A组方案。 |
| 【英文摘要】 |
OBJECTIVE:To evaluate the cost-effectiveness of two therapeutic schemes in the treatment of community acquired pneumonia.METHODS:A retrospective study was conducted in which a total of 88 cases with community acquired pneumonia were randomly assigned to receive cefoperazone sodium/sulbactam sodium(Group A) or levofloxacin(Group B).The therapeutic effects were monitored and the cost-effectiveness analyses were conducted on the two group.RESULTS:The cost was 1 803.91 yuan in Group A versus 1 599.81 yuan in Gr... |
| 【DOI】 |
CNKI:SUN:ZGYA.0.2008-08-003 |
